A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 622,342 shares of DXCM stock, worth $47.5 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
622,342
Previous 615,131 1.17%
Holding current value
$47.5 Million
Previous $69.7 Million 40.2%
% of portfolio
0.06%
Previous 0.1%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$64.0 - $116.06 $461,504 - $836,908
7,211 Added 1.17%
622,342 $41.7 Million
Q2 2024

Jul 19, 2024

BUY
$110.31 - $140.45 $3.85 Million - $4.9 Million
34,905 Added 6.02%
615,131 $69.7 Million
Q1 2024

Apr 22, 2024

BUY
$114.22 - $140.1 $48.6 Million - $59.7 Million
425,880 Added 275.93%
580,226 $80.5 Million
Q4 2023

Jan 16, 2024

BUY
$75.49 - $124.16 $830 - $1,365
11 Added 0.01%
154,346 $19.2 Million
Q3 2023

Oct 24, 2023

BUY
$86.06 - $137.93 $1.42 Million - $2.28 Million
16,504 Added 11.97%
154,335 $14.4 Million
Q2 2023

Jul 25, 2023

BUY
$112.47 - $130.98 $4.13 Million - $4.81 Million
36,725 Added 36.32%
137,831 $17.7 Million
Q1 2023

Apr 14, 2023

BUY
$104.0 - $122.92 $333,944 - $394,696
3,211 Added 3.28%
101,106 $11.7 Million
Q4 2022

Feb 08, 2023

SELL
$84.98 - $122.67 $82,940 - $119,725
-976 Reduced 0.99%
97,895 $11.1 Million
Q3 2022

Oct 25, 2022

SELL
$76.35 - $94.18 $143,843 - $177,435
-1,884 Reduced 1.87%
98,871 $7.96 Million
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $5.01 Million - $9.8 Million
73,742 Added 272.99%
100,755 $7.51 Million
Q1 2022

May 11, 2022

BUY
$94.08 - $130.2 $270,856 - $374,845
2,879 Added 11.93%
27,013 $13.8 Million
Q4 2021

Feb 08, 2022

BUY
$129.87 - $162.82 $9,350 - $11,723
72 Added 0.3%
24,134 $13 Million
Q3 2021

Nov 02, 2021

BUY
$106.71 - $143.18 $46,312 - $62,140
434 Added 1.84%
24,062 $13.2 Million
Q2 2021

Aug 11, 2021

SELL
$80.99 - $107.93 $256,981 - $342,461
-3,173 Reduced 11.84%
23,628 $10.1 Million
Q1 2021

May 14, 2021

BUY
$84.79 - $104.74 $200,528 - $247,710
2,365 Added 9.68%
26,801 $9.63 Million
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $517,296 - $693,044
6,632 Added 37.25%
24,436 $9.03 Million
Q3 2020

Nov 04, 2020

SELL
$95.51 - $112.95 $253,770 - $300,108
-2,657 Reduced 12.99%
17,804 $7.34 Million
Q2 2020

Jul 17, 2020

BUY
$62.68 - $105.34 $475,866 - $799,741
7,592 Added 58.99%
20,461 $8.3 Million
Q1 2020

Apr 21, 2020

BUY
$47.79 - $75.63 $43,775 - $69,277
916 Added 7.66%
12,869 $3.47 Million
Q4 2019

Feb 12, 2020

BUY
$36.62 - $57.29 $10,986 - $17,187
300 Added 2.57%
11,953 $2.62 Million
Q3 2019

Nov 07, 2019

BUY
$35.53 - $43.8 $29,241 - $36,047
823 Added 7.6%
11,653 $1.74 Million
Q2 2019

Aug 06, 2019

BUY
$27.84 - $38.92 $6,236 - $8,718
224 Added 2.11%
10,830 $1.62 Million
Q1 2019

May 06, 2019

BUY
$28.07 - $38.18 $64,925 - $88,310
2,313 Added 27.89%
10,606 $1.26 Million
Q4 2018

Feb 11, 2019

BUY
$26.99 - $37.37 $3,535 - $4,895
131 Added 1.6%
8,293 $994,000
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $31,335 - $49,278
1,342 Added 19.68%
8,162 $1.17 Million
Q2 2018

Jul 30, 2018

BUY
$17.54 - $25.22 $5,630 - $8,095
321 Added 4.94%
6,820 $648,000
Q1 2018

Apr 16, 2018

SELL
$13.06 - $18.54 $966 - $1,371
-74 Reduced 1.13%
6,499 $482,000
Q4 2017

Feb 09, 2018

SELL
$11.12 - $15.38 $95,276 - $131,775
-8,568 Reduced 56.59%
6,573 $377,000
Q3 2017

Oct 26, 2017

SELL
$11.36 - $18.98 $26,627 - $44,489
-2,344 Reduced 13.41%
15,141 $741,000
Q2 2017

Aug 15, 2017

BUY
N/A
17,485
17,485 $1.28 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.